Future

On July 28, 2020, the Trump administration announced that it planned to give Kodak a $765 million loan for manufacturing ingredients used in pharmaceuticals, in order to rebuild the national stockpile depleted by the COVID-19 pandemic and reduce dependency on foreign factories. The funding would come through U.S. International Development Finance Corporation, a government agency with international mandate. Within two days, the company's stock price had gained as much as 2,189% from its price at the close of July 27 on the NYSE. The New York Times reported that one day before the White House announced the loan, Kodak CEO Jim Continenza was given 1.75 million stock options, some of which he was able to execute immediately. The funding was put on hold as the U.S. Securities and Exchange Commission began probing allegations of insider trading by Kodak executives ahead of the deal’s announcement,] and the funding agency's inspector general announced scrutiny into the loan terms.